We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDPH
RNS Number : 9666F
Dechra Pharmaceuticals PLC
26 February 2018
26 February 2018
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 26 February 2018, Richard Cotton exercised a nil cost option over ordinary shares of 1p each in the Company. The option was granted to him on 7 March 2017 as part of the recruitment award referred to in the Company's Directors' Remuneration Report for the year ended 30 June 2017.
The exercise of the option was subject to a performance review, as result of which the vesting percentage is 100%.
Name Capacity Number of Total beneficial Percentage share over shareholding of issued which option following share exercised this announcement capital Richard Cotton Director 21,033 42,351 0.041%
The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") --- ----------------------------------------------------------------- a) Name Richard Cotton --- ----------------------------- ---------------------------------- 2. Reason for the notification --- ----------------------------------------------------------------- a) Position/status Director/PDMR --- ----------------------------- ---------------------------------- b) Initial notification/ Initial Notification amendment --- ----------------------------- ---------------------------------- 3. Details of the Issuer --- ----------------------------------------------------------------- a) Name Dechra Pharmaceuticals PLC --- ----------------------------- ---------------------------------- b) LEI code 213800J4UVB5OWG8VX82 --- ----------------------------- ---------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------- a) Description Ordinary Shares of 1 pence of the financial each instrument Identification ISIN: GB0009633180 code --- ----------------------------- ---------------------------------- b) Nature of Exercise of an option granted the transaction as part of a recruitment award to acquire 21,033 shares --- ----------------------------- ---------------------------------- c) Price(s) and Price(s) Volume(s) volumes(s) GBPNil Cost 21,033 --- ----------------------------- ------------------- ------------- d) Aggregated information * Aggregate volume N/A * Price --- ----------------------------- ---------------------------------- e) Date of the 2018.02.26 transaction --- ----------------------------- ---------------------------------- f) Place of the Outside a trading venue transaction --- ----------------------------- ----------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFKADQPBKDFBB
(END) Dow Jones Newswires
February 26, 2018 10:50 ET (15:50 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions